Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio.
about
Inflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patientsThe elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patientsElevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignancies.Prognostic value of PLR in various cancers: a meta-analysis.Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization.Neutrophil count is associated with survival in localized prostate cancerPrognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: a multicenter studyThe relationship between neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and thrombolysis in myocardial infarction risk score in patients with ST elevation acute myocardial infarction before primary coronary intervention.Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteinsValidation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer.Platelet-to-lymphocyte ratio but not neutrophil-to-lymphocyte ratio predicts high on-treatment platelet reactivity in clopidogrel-treated patients with acute coronary syndrome.Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer.Platelet to lymphocyte ratio in the prediction of adverse outcomes after acute coronary syndrome: a meta-analysis.The association between platelet/lymphocyte ratio and coronary artery disease severity.Novel predictors of infarct-related artery patency for ST-segment elevation myocardial infarction: Platelet-to-lymphocyte ratio, uric acid, and neutrophil-to-lymphocyte ratio.Neoplasms of the hepatobiliary system: clinical presentation, molecular pathways and diagnostics.Is combination of neutrophil to lymphocyte ratio and platelet lymphocyte ratio a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma?Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis.The relation of platelet-lymphocyte ratio and coronary collateral circulation in patients with non-ST segment elevation myocardial infarctionResection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome.A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma.Prognostic indicators based on inflammatory and nutritional factors after pancreaticoduodenectomy for pancreatic cancer.Neutrophil-lymphocyte ratio and the platelet-lymphocyte ratio predict the limb survival in critical limb ischemia.Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients.Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio combination can predict prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients undergoing surgery for gastric cancer.Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgically Resectable Pancreatic Neuroendocrine Tumors.Relationship between erectile dysfunction and the neutrophil to lymphocyte and platelet to lymphocyte ratios.Platelet-to-Lymphocyte Ratio Predicts Contrast-Induced Nephropathy in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.Relationship between platelet-to-lymphocyte ratio and coronary slow flow.Platelet-to-lymphocyte ratio predicts contrast-induced acute kidney injury in diabetic patients with ST-elevation myocardial infarction.Prognostic Value of Preoperative Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 After Resection of Ampullary Cancer.Evaluation of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and red blood cell distribution width-platelet ratio as early predictor of acute pancreatitis in pregnancy.Platelet to lymphocyte ratio as a prognostic marker in primary percutaneous coronary intervention.Relationship Between Hematologic Indices and Global Registry of Acute Coronary Events Risk Score in Patients With ST-Segment Elevation Myocardial Infarction.Patients Treated with Preoperative Chemoradiation for Pancreatic Ductal Adenocarcinoma have Impaired Bone Density, a Predictor of Distant Metastasis.Predictive Ability of Blood Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Gastrointestinal Stromal Tumors.Preoperative platelet-lymphocyte ratio is an independent prognostic factor in ampullary carcinoma following pancreaticoduodenectomy
P2860
Q27009534-74D8464D-5926-47AA-8CE2-7E5487592B9DQ33613591-D437A7F7-E1B1-4FE0-BCBF-A84843E6D97EQ33679691-09535F28-4725-4D6B-AAD8-A8DCAE5FB1CEQ33812584-1AA3B3ED-DC11-4016-A4D8-DA00900D7152Q35151707-61F7413C-629F-420C-A4EB-D0409EB58D1DQ35751637-F615DB50-ED08-485A-B4E1-6B76949929E7Q35791350-F08E36D2-334A-492D-B6A1-6DDB5299673CQ35829164-8AC27AA3-5406-4243-8AFD-9DE3CF864B03Q36089872-5F33D1F5-37AF-475E-BA23-850E11BE1D51Q36286689-675D9902-5331-4923-B524-F2809EA34FD3Q36313288-B4537E62-6536-4722-9EC9-A3632EDA9700Q37167286-3262DDBC-3974-427E-80CD-9F3BC3AF1B2AQ37457430-6615D23A-281F-4899-AFD2-D22A5D303B02Q37575880-658344D1-303D-4A7F-AF9D-53DAE7E501A9Q37680442-DC8327DA-CC07-426D-8ECA-8571725A8E05Q37680445-9111CAFC-B41C-44E7-8850-13774AB0AF9BQ37801938-9CA8C1BC-CECA-4DB6-8CE6-4590E6406218Q38381898-E0F58FAE-6209-4D2C-B85E-600B2CBE858DQ38594920-4D5C5CF0-7313-4E34-8541-6FCE28CDE115Q39393221-9D7901C1-55B3-4FFB-851B-48EBFB4505B0Q39485472-3B3228DA-3921-49EF-B268-A59614F58EEFQ39789698-495F3866-B188-4F4C-93CA-F2E8538BE49CQ40914627-3614CBCF-4E04-4251-B5CE-0F923A8FD041Q43449235-CFC58E48-74B6-4F20-A154-AEFE1E8A4B5DQ44534842-E0A5664C-D46A-47B9-8B37-59150D61EA49Q44584145-A33EA655-A4AD-4286-BBD0-DDA7ED5E06B5Q45893288-F5F94639-73B1-4308-AE6C-7D348C3BD488Q47141106-035057E7-178C-4629-B2E3-04A296C11666Q47202604-315652C6-BF06-45C3-B750-768E2BD44B21Q48086175-0D201773-280C-4C84-8B8F-B41A57B08D6EQ49484651-C3B641C9-2895-49F3-B670-9AC30E728D59Q49613379-71A84A7F-7A3D-466C-AAC9-FD22E4A23FDAQ50217905-E4C7892F-D136-41E1-A24A-E249798D8731Q50443589-344F540D-DC59-4F92-8BA9-0A0EA66BC518Q50457777-BFDB7D1D-6153-4E47-AFC0-6201163747B8Q50471718-1B6D5644-9BCF-4F81-912C-1C3E7D06F33FQ50493922-1B0E6352-2B40-43BA-8CBF-7731C5C47662Q53677374-C4162413-404F-4B29-A045-86105EAECF95Q58794884-A3066DFB-7434-4351-AA90-04984A3B2021
P2860
Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Prognosis of resected ampullar ...... and platelet-lymphocyte ratio.
@en
Prognosis of resected ampullar ...... and platelet-lymphocyte ratio.
@nl
type
label
Prognosis of resected ampullar ...... and platelet-lymphocyte ratio.
@en
Prognosis of resected ampullar ...... and platelet-lymphocyte ratio.
@nl
prefLabel
Prognosis of resected ampullar ...... and platelet-lymphocyte ratio.
@en
Prognosis of resected ampullar ...... and platelet-lymphocyte ratio.
@nl
P2093
P2860
P1476
Prognosis of resected ampullar ...... and platelet-lymphocyte ratio
@en
P2093
Fiona Campbell
Michael Raraty
Paula Ghaneh
Richard A Smith
Robert Sutton
P2860
P2888
P304
P356
10.1007/S11605-008-0554-3
P577
2008-06-10T00:00:00Z
P6179
1022255030